Clomisign 50 Tablet
Marketer
HAB Pharma
Salt Composition
Clomiphene (50mg)
Overview Clomisign 50 Tablet
Clomiphene citrate 50mg tablets aid in addressing infertility in women. This medication assists those experiencing conception difficulties stemming from ovulation irregularities or polycystic ovary syndrome (PCOS). Treatment should strictly adhere to the prescribed regimen, generally not exceeding three menstrual cycles. Commonly reported side effects include facial flushing, abdominal discomfort, mastalgia, and visual disturbances. While usually transient, persistent symptoms necessitate immediate medical consultation.
Primary Ingredients of Clomisign 50 Tablet
No text was provided to rewrite.
Uses of Clomisign 50 Tablet
Managing infertility in women
Major Benefits of Clomisign 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Clomisign 50 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Clomisign 50 Tablet:
- Nausea
- Vomiting
- Bloating
- Headache
- Enlarged ovary
- Hot flashes
- Metrorrhagia (menstrual bleeding at irregular intervals)
- Breast discomfort
- Visual disorder
How to use Clomisign 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Clomisign 50 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended.
How Clomisign 50 Tablet works:
Fertility medication Clomisign 50 Tablet, a selective estrogen receptor modulator (SERM), induces ovulation in women. Its mechanism involves stimulating the production of hormones crucial for egg release from the ovaries.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Clomisign 50 Tablet and alcohol. Seek medical advice before doing so.
PregnancyUNSAFE
Taking Clomisign 50 Tablet during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in animals and humans indicates substantial risk of fetal harm.
Breast feedingCONSULT YOUR DOCTOR
The use of Clomisign 50 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Following ingestion of a Clomisign 50 Tablet, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCONSULT YOUR DOCTOR
Data regarding Clomisign 50 Tablet use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverUNSAFE
The use of Clomisign 50 Tablets is contraindicated in individuals with hepatic impairment and should be strictly avoided. Medical advice is recommended.
What if you forget to take Clomisign 50 Tablet :
Omitting a scheduled dose of Clomisign 50 Tablet necessitates contacting your physician.
Facts to Know About Clomisign 50 Tablet
| Label | Value |
|---|---|
| Chemical Type | Stilbene Derivative of Triphenylethylene |
| Developing Habits | No. |
| Type of Treatment | Obstetrics and Gynecology |
3,018 People bought this recently